Modifiers of LRRK2 parkinsonism: new therapeutic targets.

doi:10.1016/S1474-4422(16)30243-5

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Modifiers of LRRK2 parkinsonism: new therapeutic targets.

The Lancet. Neurology - 1 Nov 2016

Ross Owen A, Rademakers Rosa

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
Share to Mutation
Share to Parkinson Disease
Share to Parkinsonian Disorders

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Open in PubMed

Identifiers

PMID: 27692901
DOI: 10.1016/S1474-4422(16)30243-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Modifiers of LRRK2 parkinsonism: new therapeutic targets.PMID 27692901Read ↗

Genetics of Parkinson's disease: LRRK2 on the rise.Semantic proximity Read ↗

Recent Developments in LRRK2-Targeted Therapy for Parkinson’s DiseaseSemantic proximity Read ↗

Development of mutation-selective LRRK2 kinase inhibitors as precision medicine for Parkinson's disease and other diseases for which carriers are at increased riskSemantic proximity Read ↗

LRRK2: cause, risk, and mechanism.Semantic proximity Read ↗

[Pathogenesis of Parkinson's disease through LRRK2 mutation].Semantic proximity Read ↗

LRRK2 inhibitor progresses for Parkinson disease.Semantic proximity Read ↗

LRRK2 mutations and ParkinsonismSemantic proximity Read ↗

Molecular Pathways Involved in LRRK2-Linked Parkinson's Disease: A Systematic Review.Semantic proximity Read ↗

PARK8 LRRK2 parkinsonism.Semantic proximity Read ↗

Parkinson's Disease: The LRRK2-G2019S mutation: opening a novel era in Parkinson's disease geneticsSemantic proximity Read ↗

LRRK2 R1441C mutation causing Parkinson's Disease in an Egyptian family.Semantic proximity Read ↗

LRRK2 and Parkinson disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.